本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Repare Therapeutics Inc.

1.37
+0.170014.17%
盤後1.35-0.0205-1.50%16:38 EDT
成交量:93.53萬
成交額:124.63萬
市值:5,823.97萬
市盈率:-0.69
高:1.41
開:1.20
低:1.20
收:1.20
資料載入中...
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/01

重要事件披露

8-K - Current report
2022/05/16

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/01

重要事件披露

8-K - Current report
2022/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals